QCG
QGENF

Quadrant Capital Group’s QIAGEN NV QGENF Stock Holding History

Quadrant Capital Group’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,096
Closed -$27K – 2230
2016
Q4 		$27K Buy
1,096
+87
+9% +$2.14K 0.01% 657
2016
Q3 		$24K Buy
1,009
+35
+4% +$833 0.02% 686
2016
Q2 		$18K Buy
974
+882
+959% +$16.3K 0.01% 758
2016
Q1 		$1K Buy
92
+44
+92% +$478 ﹤0.01% 1748
2015
Q4 		$1K Buy
+48
New +$1K ﹤0.01% 1535

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Quadrant Capital Group's QGENF Position: Q1 2017 in Review

Quadrant Capital Group sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,096 shares — an estimated $27K sold.

Quadrant Capital Group first reported a position in QGENF in Q4 2015 and held it in 5 quarters. The position peaked at $27K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Quadrant Capital Group reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Quadrant Capital Group sold 1,096 QIAGEN NV shares in Q1 2017, an estimated $27K.
  • Quadrant Capital Group first reported a position in QIAGEN NV in Q4 2015 and held it in 5 quarters.
  • Quadrant Capital Group's QIAGEN NV position peaked at $27K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Quadrant Capital Group's 13F filing for Q1 2017, filed 10 Apr 2017.